Itama Ranoraya Total Liabilities

Latest as of September 2025: Rp2.16 Trillion IDR ≈ $126.85 Million USD

Itama Ranoraya total liabilities. Based on the latest financial reports, Itama Ranoraya (IRRA) has total liabilities worth Rp2.16 Trillion IDR (≈ $126.85 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check IRRA asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Itama Ranoraya (2016–2024)

Total liabilities of Itama Ranoraya from 2016 to 2024. This chart illustrates how Itama Ranoraya's total liabilities have evolved over time, based on quarterly financial data. Explore IRRA long-term investment intensity to see how much of total assets are deployed in long-term investments.

Itama Ranoraya Competitors by Total Liabilities

The table below lists competitors of Itama Ranoraya ranked by their total liabilities.

Company Country Total Liabilities
Sun Race Sturmey-Archer Inc
TW:1526
Taiwan NT$960.72 Million
Black Canyon Ltd
AU:BCA
Australia AU$339.31K
Apex Equity Holdings Bhd
KLSE:5088
Malaysia RM161.18 Million
Trajectory Alpha Acquisition Corp
NYSE:TCOA
USA $9.81 Million
Vulcan Minerals Inc.
V:VUL
Canada CA$3.03 Million
Pyung Hwa Hldg
KO:010770
Korea ₩443.86 Billion
Shinfox Energy Co Ltd
TW:6806
Taiwan NT$43.23 Billion
Alakasa Industrindo Tbk
JK:ALKA
Indonesia Rp12.86 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Itama Ranoraya's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Itama Ranoraya.

Liquidity & Leverage Metrics

Itama Ranoraya Total Liabilities Ratios Explained

Itama Ranoraya total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.90 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 3.89 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.80 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Itama Ranoraya's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Itama Ranoraya (2016–2024)

The table below shows the annual total liabilities of Itama Ranoraya from 2016 to 2024.

Year Total Liabilities Change
2024-12-31 Rp1.15 Trillion
≈ $67.19 Million
+91.21%
2023-12-31 Rp599.69 Billion
≈ $35.14 Million
+139.99%
2022-12-31 Rp249.88 Billion
≈ $14.64 Million
-10.75%
2021-12-31 Rp279.99 Billion
≈ $16.41 Million
-4.42%
2020-12-31 Rp292.94 Billion
≈ $17.17 Million
+224.54%
2019-12-31 Rp90.26 Billion
≈ $5.29 Million
+29.66%
2018-12-31 Rp69.62 Billion
≈ $4.08 Million
-16.45%
2017-12-31 Rp83.32 Billion
≈ $4.88 Million
+407.44%
2016-12-31 Rp16.42 Billion
≈ $962.18K
--

About Itama Ranoraya

JK:IRRA Indonesia Medical Distribution
Market Cap
$30.39 Million
Rp518.69 Billion IDR
Market Cap Rank
#23500 Global
#459 in Indonesia
Share Price
Rp344.00
Change (1 day)
-2.27%
52-Week Range
Rp330.00 - Rp510.00
All Time High
Rp3619.99
About

PT Itama Ranoraya Tbk wholesale trades in laboratory and pharmaceutical equipment, and medical devices for humans in Indonesia. The company offers in vitro diagnostics products comprising rapid test and clinical laboratory; medical imaging products, including bone densitometer, C-arm, flat panel digital detector, mobile and stationary x-ray, and mammography; cardiovascular, urology, and surgical … Read more